For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

Alzheimer's Disease Insight Report: Current Therapies, Drug

Decision on Brexpiprazole for Alzheimer's Agitation Due in May

Targets, trials and tribulations in Alzheimer therapeutics

agitation that may happen with dementia due to Alzheimer's disease

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

FDA approves new drug for Alzheimer's-Associated agitation

Frontiers Agitation and Dementia: Prevention and Treatment

REXULTI® (brexpiprazole) agitation that may happen with dementia

REXULTI® (brexpiprazole), SZ

Ask the Pharmacist: New drug treats Alzheimer's agitation

Decision on Brexpiprazole for Alzheimer's Agitation Due in May